The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Cancer survival: global surveillance will stimulate health policy and improve equity
Abstract
Millions of people will continue to be diagnosed with cancer every year for the foreseeable future. These patients all need access to optimum health care. Population-based cancer survival is a key measure of the overall effectiveness of health systems in management of cancer. Survival varies very widely around the world. Global surveillance of cancer survival is needed, because unless these avoidable inequalities are measured, and reported on regularly, nothing will be done explicitly to reduce them.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Population-based cancer survival is increasingly recognised as a key indicator of the overall effectiveness of the health systems in managing care and treatment for all cancer patients.46,47”
In the citing paper
“Achieving the SDG target of a one-third reduction in premature mortality by 2030 clearly requires more effective prevention, to reduce cancer incidence. However, the 15-year time-frame is short, and achieving the target will also require investment in more effective health systems, to improve survival.46”
Citations
Cites
Jemal, A., Bray, F., Ferlay, J., Ward, E., & Forman, D. (2011) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 55,077
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
Vos, T., Flaxman, A. D., Naghavi, M., Lozano, R., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., Aboyans, V., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61729-2 · Cited by 8,291
Bray, F., Jemal, A., Grey, N., Ferlay, J., & Forman, D. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70211-5 · Cited by 2,225
Recent cancer survival in Europe: a 2000–02 period analysis of EUROCARE-4 data
Verdecchia, A., Francisci, S., Brenner, H., Gatta, G., Micheli, A., Mangone, L., & Kunkler, I. H. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70246-2 · Cited by 1,285
Coleman, M. P., Forman, D., Bryant, H., Butler, J., Rachet, B., Maringe, C., Nur, U., Tracey, E. A., Coory, M. D., Hatcher, J., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)62231-3 · Cited by 1,114
Self-citationOrigins of socio-economic inequalities in cancer survival: a review
Woods, L. M., Rachet, B., & Coleman, M. P. (2005) · Annals of Oncology · doi:10.1093/annonc/mdj007 · Cited by 1,101
Self-citationEUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentary
Sant, M., Allemani, C., Santaquilani, M., Knijn, A., Marchesi, F., & Capocaccia, R. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.11.018 · Cited by 1,020
EUROCARE-3: survival of cancer patients diagnosed 1990–94—results and commentary
Sant, M., Aareleid, T., Berrino, F., Lasota, M. B., Carli, P., Faivre, J., Grosclaude, P., Hédelin, G., Matsuda, T., Møller, H., et al. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg754 · Cited by 1,010
Cancer survival in five continents: a worldwide population-based study (CONCORD)
Coleman, M. P., Quaresma, M., Berrino, F., Lutz, J.-M., De Angelis, R., Capocaccia, R., Baili, P., Rachet, B., Gatta, G., Hakulinen, T., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70179-7 · Cited by 1,002
Self-citationBerrino, F., Angelis, R. D., Sant, M., Rosso, S., Bielska‐Lasota, M., Coebergh, J. W. W., & Santaquilani, M. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70245-0 · Cited by 806
Expansion of cancer care and control in countries of low and middle income: a call to action
Farmer, P. E., Frenk, J. M., Knaul, F. M., Shulman, L. N., Alleyne, G. A. O., Armstrong, L., Atun, R. A., Blayney, D. W., Chen, L., Feachem, R. G., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61152-x · Cited by 797
Karim‐Kos, H. E., de Vries, E., Soerjomataram, I., Lemmens, V. E. P. P., Siesling, S., & Coebergh, J. W. W. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2007.12.015 · Cited by 759
Delivering affordable cancer care in high-income countries
Sullivan, R., Peppercorn, J., Sikora, K., Zalcberg, J., Meropol, N. J., Amir, E., Khayat, D., Boyle, P., Autier, P., Tannock, I. F., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70141-3 · Cited by 718
Cancer survival in Africa, Asia, and Central America: a population-based study
Sankaranarayanan, R., Swaminathan, R., Brenner, H., Chen, K., Chia, K. S., Chen, J., Law, S. C., Ahn, Y., Xiang, Y., Yeole, B. B., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70335-3 · Cited by 634
Standard cancer patient population for age standardising survival ratios
Corazziari, I., Quinn, M., & Capocaccia, R. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.07.002 · Cited by 589
Halpern, M. T., Ward, E., Pavluck, A., Schrag, N. M., Bian, J., & Chen, A. Y. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70032-9 · Cited by 567
The evolution of the population-based cancer registry
Parkin, D. M. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1948 · Cited by 420
Anderson, B. O., Cazap, E. L., Saghir, N. S. E., Yip, C. H., Khaled, H. M., Otero, I. V., Adebamowo, C., Badwe, R. A., & Harford, J. B. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70031-6 · Cited by 319
Abandonment of treatment for childhood cancer: position statement of a SIOP PODC Working Group
Mostert, S., Arora, R. S., Arreola, M., Bagai, P., Friedrich, P., Gupta, S., Kaur, G., Koodiyedath, B., Kulkarni, K., Lam, C. G., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70128-0 · Cited by 265
Effects of health insurance and race on colorectal cancer treatments and outcomes
Roetzheim, R. G., Pal, N., Gonzalez, E. C., Ferrante, J. M., Durme, D. J. V., & Krischer, J. P. (2000) · American Journal of Public Health · doi:10.2105/ajph.90.11.1746 · Cited by 254
The size of the prize for earlier diagnosis of cancer in England
Richards, M. A. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605402 · Cited by 224
the International Cancer Benchmarking Partnership Module 2 Working Group, Forbes, L. J. L., Simon, A. E., Warburton, F. G., Boniface, D. R., Brain, K. E., Dessaix, A., Donnelly, D. W., Haynes, K., Hvidberg, L., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2012.542 · Cited by 216
Maringe, C., Walters, S., Rachet, B., Butler, J., Fields, T., Finan, P. J., Maxwell, R. J., Nedrebø, B. S., Påhlman, L., Sjövall, A., et al. (2013) · Acta Oncologica · doi:10.3109/0284186x.2013.764008 · Cited by 204
Self-citationSocioeconomic inequalities in cancer survival in England after the NHS cancer plan
Rachet, B., Ellis, L., Maringe, C., Chu, T. P. C., Nur, U., Quaresma, M., Shah, A., Walters, S., Woods, L. M., Forman, D., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605752 · Cited by 198
Self-citationRadiation dose, chemotherapy and risk of osteosarcoma after solid tumours during childhood
Vu, B. L., de Vathaire, F., Shamsaldin, A., Hawkins, M. M., Grimaud, E., Hardiman, C., Diallo, I., Vassal, G., Bessa, E., Campbell, S., et al. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980729)77:3 · Cited by 193
Rachet, B., Maringe, C., Nur, U., Quaresma, M., Shah, A., Woods, L. M., Ellis, L., Walters, S., Forman, D., Steward, J., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70028-2 · Cited by 181
Self-citationChildhood acute leukemias are frequent in Mexico City: descriptive epidemiology
Pérez‐Saldívar, M. L., Fajardo‐Gutiérrez, A., Bernáldez-Rı́os, R., Martínez‐Avalos, A., Medina‐Sansón, A., Espinoza‐Hernández, L. E., Flores-Chapa, J. D. D., Amador‐Sánchez, R., Peñaloza‐González, J. G., Rodríguez, F. J. Á., et al. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-355 · Cited by 170
Vedsted, P., & Olesen, F. (2011) · British Journal of General Practice · doi:10.3399/bjgp11x588484 · Cited by 160
What if cancer survival in Britain were the same as in Europe: how many deaths are avoidable?
Abdel-Rahman, M., Stockton, D., Rachet, B., Hakulinen, T., & Coleman, M. P. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605401 · Cited by 160
Self-citationWalters, S., Maringe, C., Butler, J., Brierley, J. D., Rachet, B., & Coleman, M. P. (2012) · International Journal of Cancer · doi:10.1002/ijc.27651 · Cited by 147
Self-citationEuropean health systems and cancer care
Micheli, A., Coebergh, J. W. W., Mugno, E., Massimiliani, E., Sant, M., Oberaigner, W., Holub, J., Storm, H. H., Forman, D., Quinn, M. J., et al. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg753 · Cited by 146
Breast cancer survival in the US and Europe: A CONCORD high‐resolution study
Allemani, C., Sant, M., Weir, H. K., Richardson, L. C., Baili, P., Storm, H. H., Siesling, S., Torrella-Ramos, A., Voogd, A. C., Aareleid, T., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27725 · Cited by 144
Self-citationEthnic Inequalities in Cancer Survival in New Zealand: Linkage Study
Jeffreys, M., Stevanovic, V., Tobias, M. I., Lewis, C., Ellison‐Loschmann, L., Pearce, N. E., & Blakely, T. A. (2005) · American Journal of Public Health · doi:10.2105/ajph.2004.053678 · Cited by 121
Cancer survival in England and Wales at the end of the 20th century
Rachet, B., Woods, L. M., Mitry, E., Riga, M., Cooper, N. S., Quinn, M. J., Steward, J., Brenner, H., Estève, J., Sullivan, R. J., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604571 · Cited by 119
Self-citationEssential drugs for cancer therapy: A World Health Organization consultation
Sikora, K., Advani, S., Koroltchouk, V., Magrath, I. T., Lévy, L., Pinedo, H. M., Schwartsmann, G., Tattersall, M., & Yan, S. (1999) · Annals of Oncology · doi:10.1023/a:1008367822016 · Cited by 106
The cure of cancer: A European perspective
Francisci, S., Capocaccia, R., Grande, E., Santaquilani, M., Simonetti, A., Allemani, C., Gatta, G., Sant, M., Zigon, G., Bray, F., et al. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.11.034 · Cited by 106
Closing the Cancer Divide: An Equity ImperativePreprint
Knaul, F. M., Gralow, J. R., Atun, R. A., & Bhadelia, A. (2012) · SSRN Electronic Journal · Cited by 85
Race and Outcomes: Is This the End of the Beginning for Minority Health Research?
Brawley, O. W., & Freeman, H. P. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.22.1908 · Cited by 85
Disaggregating the Effects of Race and Poverty on Breast Cancer Outcomes
Brawley, O. W. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.7.471 · Cited by 81
How many deaths have been avoided through improvements in cancer survival?
Richards, M. A. (2000) · BMJ · doi:10.1136/bmj.320.7239.895 · Cited by 81
Ellis, L., Coleman, M. P., & Rachet, B. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.10.008 · Cited by 79
Self-citationVariation in ‘standard care’ for breast cancer across Europe: A EUROCARE-3 high resolution study
Allemani, C., Storm, H. H., Voogd, A. C., Holli, K., Izarzugaza, I., Torrella-Ramos, A., Bielska‐Lasota, M., Aareleid, T., Ardanáz, E., Colonna, M., et al. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.02.016 · Cited by 76
Responding to the challenge of cancer in Europe
Venn, A. (2009) · Australian and New Zealand Journal of Public Health · doi:10.1111/j.1753-6405.2009.00395.x · Cited by 76
Pérez‐Cuevas, R., Doubova, S. V., Zapata‐Tarrés, M., Flores‐Hernández, S., Frazier, A. L., Galindo, C. R., Cortés-Gallo, G., Chertorivski, S., & Muñoz‐Hernández, O. (2012) · Pediatric Blood & Cancer · doi:10.1002/pbc.24265 · Cited by 74
Measurement of Progress Against Cancer
Extramual Committee To Assess Measures of Progress Against Cancer (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.10.825 · Cited by 74
Philipson, T., Eber, M., Lakdawalla, D. N., Corral, M., Conti, R. M., & Goldman, D. P. (2012) · Health Affairs · doi:10.1377/hlthaff.2011.1298 · Cited by 73
Sondik, E. J. (1990) · PubMed · Cited by 72
Education, survival and avoidable deaths in cancer patients in Finland
Pokhrel, A., Martikainen, P., Pukkala, ., Rautalahti, M. T., Seppä, K., & Hakulinen, T. R. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605861 · Cited by 70
Beral, V., & Peto, R. (2010) · BMJ · doi:10.1136/bmj.c4112 · Cited by 57
Rivera‐Luna, R., Correa‐González, C., Altamirano‐Alvarez, E., Sanchez-Zubieta, F. A., Cárdenas-Cardos, R. D. S., Escamilla-Asiaín, G., Olaya‐Vargas, A., Bautista-Márquez, A., & Aguilar‐Romo, M. (2012) · International Journal of Cancer · doi:10.1002/ijc.27771 · Cited by 50
Dickman, P. W., Gibberd, R. W., & Hakulinen, T. R. (1997) · Journal of Epidemiology & Community Health · doi:10.1136/jech.51.3.289 · Cited by 49
Woods, L. M., Coleman, M. P., Lawrence, G., Rashbass, J., Berrino, F., & Rachet, B. (2011) · BMJ · doi:10.1136/bmj.d3399 · Cited by 48
Self-citationEloranta, S., Adolfsson, J., Lambert, P. C., Stattin, P. E., Akre, O., Andersson, T., & Dickman, P. W. (2013) · Cancer Causes & Control · doi:10.1007/s10552-012-0141-5 · Cited by 46
NHS Outcomes Framework 2012–13
Gladman, J. R. F., Harwood, R., Conroy, S., Logan, P., Elliott, R. A., Jones, R., Lewis, S., Dyas, J., Schneider, J. M., Porock, D. C., et al. (2015) · Cited by 44
Life Tables for World-Wide Comparison of Relative Survival for Cancer (CONCORD Study)
Baili, P., Micheli, A., Angelis, R. D., Weir, H. K., Francisci, S., Santaquilani, M., Hakulinen, T. R., Quaresma, M., the CONCORD Working Group, & Coleman, M. P. (2008) · Tumori Journal · doi:10.1177/030089160809400503 · Cited by 42
Self-citationAn appeal to world leaders: stop cancer now
Cavalli, F. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60059-8 · Cited by 41
A Survey of Public Funding of Cancer Research in the European Union
Eckhouse, S., & Sullivan, R. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030267 · Cited by 41
Aareleid, T., & Brenner, H. (2002) · International Journal of Cancer · doi:10.1002/ijc.10663 · Cited by 37
Introduction: The prevention agenda
O’Callaghan, T. (2011) · Nature · doi:10.1038/471s2a · Cited by 34
Estimates of cancer incidence, mortality and survival in aboriginal people from NSW, Australia
Morrell, S. L., You, H., & Baker, D. F. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-168 · Cited by 30
Health Systems Performance and Cancer Outcomes
Karanikolos, M., Ellis, L., Coleman, M. P., & McKee, M. (2013) · JNCI Monographs · doi:10.1093/jncimonographs/lgt003 · Cited by 30
Self-citationFunnel plots for population-based cancer survival: principles, methods and applications
Quaresma, M., Coleman, M. P., & Rachet, B. (2013) · Statistics in Medicine · doi:10.1002/sim.5953 · Cited by 28
Self-citationChildhood leukaemia: long-term excess mortality and the proportion ‘cured’
Shah, A., Stiller, C. A., Kenward, M. G., Vincent, T. J., Eden, T. O. B., & Coleman, M. P. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604466 · Cited by 27
Self-citationCancer survival in Eastern and Western Germany after the fall of the iron curtain
GEKID Cancer Survival Working Group, Jansen, L., Gondos, Á., Eberle, A., Emrich, K., Holleczek, B., Katalinic, A., & Brenner, H. (2012) · European Journal of Epidemiology · doi:10.1007/s10654-012-9723-5 · Cited by 22
Cancer survival statistics should be viewed with caution
Autier, P., Boniol, M., Héry, C., Masuyer, E., & Ferlay, J. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70354-6 · Cited by 22
[Cancer survival before and after initiating the Danish Cancer Control plan].
Storm, H. H., Gislum, M., & Engholm, G. (2008) · PubMed · Cited by 18
Avoidable deaths and random variation in patients' survival
Seppä, K., Hakulinen, T. R., & Läärä, E. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.169 · Cited by 15
Cochrane, J. M. (2000) · The Lancet · doi:10.1016/s0140-6736(05)74463-9 · Cited by 10
Cookson, J. (2000) · The Lancet · doi:10.1016/s0140-6736(05)74461-5 · Cited by 10
Obama: health-care reform, part two
Oncology, T. L. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70526-0 · Cited by 2
Research works printed but not linked: 2
- 2010, World Cancer Declaration, UICC
- Beniaiche, 2012, La déficience de notre système de santé est à l'origine du taux de survie si bas [in French], El Watan [Algeria]
Cited by
Sorted by citations
Fitzmaurice, C., Allen, C., Barber, R. M., Barregård, L., Bhutta, Z. A., Brenner, H., Dicker, D., Chimed‐Ochir, O., Dandona, R., Dandona, L., et al. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2016.5688 · Cited by 6,318
Allemani, C., Matsuda, T., Di Carlo, V., Harewood, R., Matz, M., Nikšić, M., Bonaventure, A., Valkov, M., Johnson, C. J., Estève, J., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)33326-3 · Cited by 6,145
Self-citationAllemani, C., Weir, H. K., Carreira, H., Harewood, R., Spika, D., Wang, X.-S., Bannon, F., Ahn, J. V., Johnson, C. J., Bonaventure, A., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)62038-9 · Cited by 2,614
Self-citationZeng, H., Chen, W., Zheng, R., Zhang, S., Ji, J. S., Zou, X., Xia, C., Sun, K., Yang, Z., Li, H., et al. (2018) · The Lancet Global Health · doi:10.1016/s2214-109x(18)30127-x · Cited by 1,558
Curigliano, G., Lenihan, D., Fradley, M., Ganatra, S., Barac, A., Blaes, A., Herrmann, J., Porter, C., Lyon, A. R., Lancellotti, P., et al. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2019.10.023 · Cited by 1,031
Metadata
- Authors
- Coleman, M. P.
- Affiliations
- Cancer Research UK (GB)
- Corresponding author
- Coleman, Michel P
- ORCID
- Coleman, Michel P
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2014-02
- Volume
- 383
- Issue
- 9916
- Pages
- 564-573
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2057721627
- Cited by
- 370
- References
- 72
- Citations by year
- 2026: 13 · 2025: 12 · 2024: 8 · 2023: 8 · 2022: 13 · 2021: 13 · 2020: 222 · 2019: 14 · 2018: 18 · 2017: 16 · 2016: 16 · 2015: 9 · 2014: 7
- FWCI
- 1.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (submittedVersion)
- Funders
- Cancer Research UK (11700, 16148)
- Topics
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Economic and Financial Impacts of Cancer
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advances in Oncology and Radiotherapy
- Keywords
- cancer survival, health equity, health policy, access to cancer care, health system effectiveness, cancer epidemiology
- MeSH terms
- Adult, Aged, Health Planning, Health Policy, Health Services Accessibility, Humans, International Cooperation, Middle Aged, Neoplasms, Global Health, Survival Analysis, Cost of Illness, Healthcare Disparities, Mortality, Premature, Public Health Surveillance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review